KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,788 | -88.3% | 1,288 | -87.4% | 0.00% | -100.0% |
| Q1 2023 | $1,859,086 | -5.1% | 10,235 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $1,958,712 | -11.2% | 9,968 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $2,205,000 | -46.0% | 9,800 | -69.6% | 0.00% | -50.0% |
| Q2 2022 | $4,080,000 | -1.4% | 32,245 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $4,136,000 | +0.9% | 32,621 | +1.2% | 0.00% | +33.3% |
| Q4 2021 | $4,100,000 | -16.6% | 32,225 | -21.7% | 0.00% | -25.0% |
| Q3 2021 | $4,919,000 | +22.3% | 41,165 | +16.5% | 0.00% | 0.0% |
| Q2 2021 | $4,023,000 | – | 35,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |